Yes. We offer GMP-compliant fill finish services for viral vectors, allogeneic cell therapies, and other small-batch biologics. Our fill finish suite includes a Grade C cleanroom and Grade A isolator, suitable for clinical-stage vial or bag filling. We provide this as a standalone service or integrated within a broader manufacturing programme, with full GMP oversight […]
Apr 11, 2025
Can we support fill finish?
Yes. We offer GMP-compliant fill finish services for viral vectors, allogeneic cell therapies, and other small-batch biologics. Our fill finish suite includes a Grade C cleanroom and Grade A isolator, suitable for clinical-stage vial or bag filling. We provide this as a standalone service or integrated within a broader manufacturing programme, with full GMP oversight and documentation.
Latest News
eXmoor Pharma and Signadori Bio launch partnership to develop next-generation monocyte-based cell therapy for solid tumours
Jun 17, 2025
Scaling Gene Therapy Production: From Bench to Clinic
May 30, 2025
eXmoor Pharma and KU Leuven announce strategic partnership to accelerate cell and gene therapy innovation through new venture
May 13, 2025
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.